Market overview
The
global organ transplantation
market share, as per the study conducted by Market Research Future (MRFR), is
expected to reach at a compound annual growth rate of 9.5% during the forecast
period of 2023 to 2032.
Organ
transplantation involves the process of replacing the diseased and damaged
organ of an individual with a healthy organ. It is one of the great
advancements in the modern healthcare landscape. This medical procedure has
evolved and advanced over the years, thereby enhancing the clinical effectivity
of the same. Organs are donated by either some living donor or it is harvested
from the brain-dead organ donors. Dysfunction of the organ caused due to
diseases like cancer, severe injuries, failure of the organ, and due to genetic
disorders require the need for organ transplant procedures. Organs such as
heart, liver, lungs, kidney, and many more can be transplanted through this
procedure.
The
transplantation process is carried out primarily with the brain-dead patient
whose other organs are in a healthy state and can be used to save the life of
another person. An increasing number of organ transplantation surgeries
undertaken globally is one of the major drivers of the future of organ
transplants market. Increasing prevalence of chronic diseases,
advancements in technology, changing lifestyle of individuals, and the rising
aging population are some of the other key factors influencing the growth of
the global market.
Competitive Landscape
The
global organ transplantation market players of various notable players
TransMedic, Inc. (US), Transonic (US), Novartis International AG (Switzerland),
OrganOX Limited (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Terumo Medical
Corporation (US), Preservation Solutions, Inc. (US), Transplant Biomedical
(UK), Accord Healthcare GmbH (Spain), Astellas Pharma, Inc (Japan), Pfizer,
Inc. (US), Veloxis Pharmaceuticals A/S (Denmark), Bio Med Pvt. Ltd. (US),
GlaxoSmithKline Plc. (UK), Sanofi (France), and others.
Market Segmentation
The
global organ transplantation
market outlook segmentation is done as per the following dynamics: type.
End-users, products, and treatment.
By
type, the market comprises of lungs, heart, liver, kidney, and others.
By
products, the market segments into tissue products, organ preservation
solutions, transplant diagnostics, and others.
By
type of treatment, the market includes immunosuppressant, analgesic, and other.
Immunosuppressant is narrowed down into mTOR inhibitor, calcineurin inhibitors,
steroids, antiproliferative agents, and other. Whereas calcineurin inhibitors
are divided into tacrolimus and cyclosporine. And, mTOR inhibitor is broken
down into sirolimus and everolimus.
By
type of transplant, the market includes allograft, xenograft, autograft,
allotransplantation, xenotransplantation, and others.
By
end users, the market comprises transplant centers, hospitals, and others.
Regional Analysis
The
regional segmentation of the organ transplantation market insight covers the
following regions: Europe, Americas, Asia Pacific, and the Middle East and
Africa.
America
holds the largest share of the market in the global standings of organ
transplantation. This is due to the increasing prevalence of chronic diseases.
Other key factors influencing the growth of the market in this region are the
rising aging population, an increase in the number of organ transplantation
cases, and striking developments in technology.
Europe
stands second in the global organ transplantation market due to various
essential factors or drivers. The regional market is driven by the developed
infrastructure, encouragement for the emergence of new organizations, and
increasing expenditures on healthcare.
Asia
Pacific is expected to grow at a notable pace in the near future and cement its
position as one of the key regions in the global organ transplantation market.
Factors such as fast-paced development in the healthcare industry, presence of
a huge patient population pool, and the availability of skilled professionals
are the major growth drivers of the market. However, in the Middle East and
Africa region, the poor economical condition coupled with the limited growth of
the healthcare sector is expected to be responsible for the meagre growth of
the region.
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
United
States of America
No comments:
Post a Comment